Possible role of neuropeptides in obsessive compulsive disorder (Q33546754)

27 July 2017

1 reference

title

Possible role of neuropeptides in obsessive compulsive disorder (English)

1 reference

obsessive-compulsive disorder

27 July 2017

main subject

1 reference

McDougle CJ

1

1 reference

27 July 2017

Barr LC

series ordinal

2

1 reference

27 July 2017

Goodman WK

series ordinal

3

1 reference

27 July 2017

Price LH

series ordinal

4

1 reference

27 July 2017

publication date

1 January 1999

1 reference

27 July 2017

published in

Psychoneuroendocrinology

1 reference

27 July 2017

volume

24

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

1-24

1 reference

Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

CSF somatostatin in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Oxytocin and vasopressin secretion in monkeys administered apomorphine and a D2 receptor agonist

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Intranasal oxytocin in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Corticotropin releasing factor stimulation test in obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Facilitation of inhibitory avoidance by hypertonic saline is reversed by a vasopressin and a nicotinic antagonist

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Diabetes insipidus and obsessional neurosis. A syndrome

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Apparent down-regulation of rat brain mu- and kappa-opioid binding sites labelled with [3H]cycloFOXY following chronic administration of the potent 5-hydroxytryptamine reuptake blocker, clomipramine

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Vasopressin and electrophysiological signs of attention in man.

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Striatal neurochemistry of dynorphin-(1-13): in vivo electrochemical semidifferential analyses

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Vasopressin and oxytocin—their role in neurotransmission

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Oxytocin facilitates the sexual receptivity of estrogen-treated female rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Oxytocin and sexual behavior

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: A pilot study

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Enhanced stress responsivity of Tourette syndrome patients undergoing lumbar puncture

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Elevated cerebrospinal fluid corticotropin-releasing ractor in Tourette's syndrome: Comparison to obsessive compulsive disorder and normal controls

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Topography of binding sites for neurohypophyseal hormones in rat brain

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Behavioral responses to intracerebroventricularly administered neurohypophyseal peptides in mice

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Oxytocin in obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

CRF-induced excessive grooming behavior in rats and mice

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

1 reference

7 January 2021

The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Intranasal oxytocin in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Vasopressin does not enhance memory processes: a study in human twins

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Influence of oxytocin on human memory processes

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Chronic administration of clomipramine inhibits morphine hot plate analgesia

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Pharmacological characteristics and anatomical distribution of [3H]oxytocin-binding sites in the Wistar rat brain studied by autoradiography

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Tourette syndrome and the opioid system

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

The induction of excessive grooming in the rat by intraventricular application of peptides derived from ACTH: Structure-activity studies

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Opiate antagonists suppress ACTH(1-24)-induced excessive grooming in the rat

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

The Yale-Brown Obsessive Compulsive Scale. II. Validity

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: Absence of symptom exacerbation

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Gilles de la Tourette's syndrome. A postmortem neuropathological and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Somatostatin and thyrotropin releasing hormone: Central effect on sleep and motor system

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Serotonergic Function in Obsessive-Compulsive Disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Naloxone administration in obsessive-compulsive disorder: report of two cases

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Obsessive-compulsive disorder and serotonin: is there a connection?

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Oxytocin — A neuropeptide for affiliation: Evidence from behavioral, receptor autoradiographic, and comparative studies

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Toward a neuroanatomy of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Behavioral activity of some novel aporphines in rats with 6-hydroxydopamine lesions of caudate or nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Contrasting effects of acute vs. chronic tricyclic antidepressant treatment on central morphine analgesia

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Behavioral effects of naloxone infusion in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

The role of oxytocin-dopamine interactions in cocaine-induced locomotor hyperactivity

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Distribution of neurohypophysial hormones in the brain

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

CSF somatostatin in childhood psychiatric disorders: a preliminary investigation

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

A controlled trial of propoxyphene and naltrexone in patients with tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Chronic dietary treatment with antidepressants decrease brain Met-enkephalin-like immunoreactivity in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Elevated CSF dynorphin A [1-8] in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

The role of central oxytocin in obsessive compulsive disorder and related normal behavior

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Influence of vasopressin on learning and memory

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

123Ibeta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Oxytocin in Alzheimer's disease: postmortem brain levels

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Methadone treatment of Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder, and healthy controls

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

CRF in the paraventricular nucleus of the hypothalamus induces dose-related behavioral profile in rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Receptors to vasopressin and other hormones in the mammalian kidney

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Onset of obsessive-compulsive disorder in pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Oxytocin induces maternal behavior in virgin female rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Clinical comparison of Tourette's disorder and obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Clinical characteristics and family history in DSM-III obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Obsessive compulsive disorder in children and adolescents: phenomenology and family history

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Serum antibody for somatostatin-14 and prodynorphin 209-240 in patients with obsessive-compulsive disorder, schizophrenia, Alzheimer's disease, multiple sclerosis, and advanced HIV infection.

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

CSF Somatostatin in Affective Illness

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Role of oxytocin in the neuroadaptation to drugs of abuse

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Ontogeny of oxytocin receptors in rat forebrain: a quantitative study

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Projections from vasopressin, oxytocin, and neurophysin neurons to neural targets in the rat and human

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Arginine8-vasopressin affects catecholamine metabolism in specific brain nuclei

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Appearance and transient expression of oxytocin receptors in fetal, infant, and peripubertal rat brain studied by autoradiography and electrophysiology

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Neurohypophyseal hormones and excessive grooming behaviour

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Somatostatin and (D-Trp8, D-Cys14)-somatostatin delay extinction and reverse electroconvulsive shock induced amnesia in rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Effects of intracerebroventricularly administered somatostatin on passive avoidance, shuttle-box behaviour and open-field activity in rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Effects of vasopressin on human memory functions

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Social status in pairs of male squirrel monkeys determines the behavioral response to central oxytocin administration

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(98)50046-8

7 January 2021

10.1016/S0306-4530(98)00046-8

Identifiers

DOI

1 reference

27 July 2017

1 reference